Clinical Trials Browser

Lymphoma × devimistat × Lymphoid × Clear all

NCT03793140 2025-04-16

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

NCT00741403 2016-12-29

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Phase 1 Completed

Lymphoma, Neoplasm Metastasis, Neoplasms, Recurrence